dose for aod9604 AOD 9604: The Complete Evidence-Based Guide to the F AOD-9604 Peptide Therapy - Wellness,
Description
Factors affecting individual response Response to AHK-Cu varies substantially between individuals
Available in 46 states not available in Arkansas, Indiana, Minnesota, or South Carolina
Initially developed for obesity treatment, AOD9604 showed weight-reducing effects in rodent models comparable to those of full-length GH, but without inducing diabetes or stimulating IGF-1 production
In the short term, some individuals may experience a quick boost in energy and improved mood shortly after receiving the injection, often within a few days
But, do they work
